oral compounded tirzepatide Tirzepatide: Availability, Alternatives, and More Tirzepatide | DirectMeds

For comparison, patients taking the maximum dose of Zepbound (10 mg to 15 mg) lost 20.9% after 72 weeks

FDA Status: Not yet approved (currently in Phase 3 clinical trials) How It Works: Stimulates GLP-1, GIP, and glucagon receptors to enhance metabolism, burn fat, and suppress appetite Common Side Effects (in trials): Nausea, mild vomiting, transient fatigue, and slight increases in heart rate Expected Weight Loss Results: Early studies suggest greater average weight loss than both semaglutide and tirzepatide Because its still under investigation, retatrutides availability is limited to clinical trial participants or research programs until FDA approval is secured

Debers consultar con tu farmacia para confirmar el precio y la disponibilidad del medicamento, ya que puede haber escasez de suministros

Afamelanotide is a distinct linear analog with a specific approved indication